118 related articles for article (PubMed ID: 27297135)
21. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
Sacco E; Spinelli M; Vanoni M
Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
[TBL] [Abstract][Full Text] [Related]
22. p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling.
Pamonsinlapatham P; Hadj-Slimane R; Lepelletier Y; Allain B; Toccafondi M; Garbay C; Raynaud F
Biochimie; 2009 Mar; 91(3):320-8. PubMed ID: 19022332
[TBL] [Abstract][Full Text] [Related]
23. The Ras-Membrane Interface: Isoform-specific Differences in The Catalytic Domain.
Parker JA; Mattos C
Mol Cancer Res; 2015 Apr; 13(4):595-603. PubMed ID: 25566993
[TBL] [Abstract][Full Text] [Related]
24. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
25. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
[TBL] [Abstract][Full Text] [Related]
26. Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin.
Vetter IR; Hofmann F; Wohlgemuth S; Herrmann C; Just I
J Mol Biol; 2000 Sep; 301(5):1091-5. PubMed ID: 10966807
[TBL] [Abstract][Full Text] [Related]
27. Herpesviruses: hijacking the Ras signaling pathway.
Filippakis H; Spandidos DA; Sourvinos G
Biochim Biophys Acta; 2010 Jul; 1803(7):777-85. PubMed ID: 20303365
[TBL] [Abstract][Full Text] [Related]
28. Signal transduction via Ras.
Wittinghofer A
Biol Chem; 1998; 379(8-9):933-7. PubMed ID: 9792425
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Approaches to RAS Mutation.
Scott AJ; Lieu CH; Messersmith WA
Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
[TBL] [Abstract][Full Text] [Related]
30. RAS Proteins and Their Regulators in Human Disease.
Simanshu DK; Nissley DV; McCormick F
Cell; 2017 Jun; 170(1):17-33. PubMed ID: 28666118
[TBL] [Abstract][Full Text] [Related]
31. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
32. gRASping the redox lever to modulate cancer cell fate signaling.
Foo CHJ; Pervaiz S
Redox Biol; 2019 Jul; 25():101094. PubMed ID: 30638892
[TBL] [Abstract][Full Text] [Related]
33. Ras Conformational Ensembles, Allostery, and Signaling.
Lu S; Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R; Zhang J
Chem Rev; 2016 Jun; 116(11):6607-65. PubMed ID: 26815308
[TBL] [Abstract][Full Text] [Related]
34. p120RasGAP-mediated activation of c-Src is critical for oncogenic Ras to induce tumor invasion.
Chan PC; Chen HC
Cancer Res; 2012 May; 72(9):2405-15. PubMed ID: 22411953
[TBL] [Abstract][Full Text] [Related]
35. The role of protein tyrosine phosphatase 1B in Ras signaling.
Dubé N; Cheng A; Tremblay ML
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1834-9. PubMed ID: 14766979
[TBL] [Abstract][Full Text] [Related]
36. Ras oncogenes and their downstream targets.
Rajalingam K; Schreck R; Rapp UR; Albert S
Biochim Biophys Acta; 2007 Aug; 1773(8):1177-95. PubMed ID: 17428555
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
38. RAS oncogenic signal upregulates EZH2 in pancreatic cancer.
Fujii S; Fukamachi K; Tsuda H; Ito K; Ito Y; Ochiai A
Biochem Biophys Res Commun; 2012 Jan; 417(3):1074-9. PubMed ID: 22222375
[TBL] [Abstract][Full Text] [Related]
39. Current status of the development of Ras inhibitors.
Shima F; Matsumoto S; Yoshikawa Y; Kawamura T; Isa M; Kataoka T
J Biochem; 2015 Aug; 158(2):91-9. PubMed ID: 26100833
[TBL] [Abstract][Full Text] [Related]
40. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
